Zoubeidi A - Search Results

1

Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells.

Shiota M, Zardan A, Takeuchi A, Kumano M, Beraldi E, Naito S, Zoubeidi A, Gleave ME. Shiota M, et al. Among authors: zoubeidi a. Cancer Res. 2012 Oct 15;72(20):5261-72. doi: 10.1158/0008-5472.CAN-12-0254. Epub 2012 Aug 15. Cancer Res. 2012. PMID: 22896337

2

Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.

Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, Rennie P, Nelson C, Gleave M. Zoubeidi A, et al. Cancer Res. 2007 Nov 1;67(21):10455-65. doi: 10.1158/0008-5472.CAN-07-2057. Cancer Res. 2007. PMID: 17974989 Free article.

3

Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.

Hadaschik BA, Ettinger S, Sowery RD, Zoubeidi A, Andersen RJ, Roberge M, Gleave ME. Hadaschik BA, et al. Among authors: zoubeidi a. Int J Cancer. 2008 May 15;122(10):2368-76. doi: 10.1002/ijc.23406. Int J Cancer. 2008. PMID: 18240145 Clinical Trial.

4

Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.

Sowery RD, Hadaschik BA, So AI, Zoubeidi A, Fazli L, Hurtado-Coll A, Gleave ME. Sowery RD, et al. Among authors: zoubeidi a. BJU Int. 2008 Aug;102(3):389-97. doi: 10.1111/j.1464-410X.2008.07618.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336596 Clinical Trial.

5

Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.

Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, Gleave ME, So AI. Hadaschik BA, et al. Among authors: zoubeidi a. BJU Int. 2008 Aug 5;102(5):610-6. doi: 10.1111/j.1464-410X.2008.07669.x. Epub 2008 Apr 2. BJU Int. 2008. PMID: 18384625

6

Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer.

Chi KN, Zoubeidi A, Gleave ME. Chi KN, et al. Among authors: zoubeidi a. Expert Opin Investig Drugs. 2008 Dec;17(12):1955-62. doi: 10.1517/13543780802528609. Expert Opin Investig Drugs. 2008. PMID: 19012510 Review.

7

Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.

Locke JA, Guns ES, Lehman ML, Ettinger S, Zoubeidi A, Lubik A, Margiotti K, Fazli L, Adomat H, Wasan KM, Gleave ME, Nelson CC. Locke JA, et al. Among authors: zoubeidi a. Prostate. 2010 Feb 15;70(3):239-51. doi: 10.1002/pros.21057. Prostate. 2010. PMID: 19790237

8

Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.

Zoubeidi A, Ettinger S, Beraldi E, Hadaschik B, Zardan A, Klomp LW, Nelson CC, Rennie PS, Gleave ME. Zoubeidi A, et al. Mol Cancer Res. 2010 Jan;8(1):119-30. doi: 10.1158/1541-7786.MCR-09-0277. Epub 2010 Jan 12. Mol Cancer Res. 2010. PMID: 20068069 Free PMC article.

9

Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.

Zoubeidi A, Chi K, Gleave M. Zoubeidi A, et al. Clin Cancer Res. 2010 Feb 15;16(4):1088-93. doi: 10.1158/1078-0432.CCR-09-2917. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145158 Free PMC article.

10

TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.

Tavassoli P, Wafa LA, Cheng H, Zoubeidi A, Fazli L, Gleave M, Snoek R, Rennie PS. Tavassoli P, et al. Among authors: zoubeidi a. Mol Endocrinol. 2010 Apr;24(4):696-708. doi: 10.1210/me.2009-0229. Epub 2010 Feb 24. Mol Endocrinol. 2010. PMID: 20181722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters